NLRP3 and skin sensitization: The observed suppression of NiSO4-induced NLRP3 expression after topical administration of PsA-D in the skin model offers a promising strategy to modulate this response, reducing the activation of DDCs and potentially other immune cells, thereby limiting the inflammatory cycle that contributes to the development and progression of skin sensitization.